Arena Pharmaceuticals Inc. - Health Care Sector

A comprehensive view of Arena Pharmaceuticals Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer to discontinue three multiple midstage therapies acquired from Arena Pharmaceuticals, leaving only etrasimod; Pfizer ends temanogrel, APD418, PF-06480605 for ulcerative colitis and RIST472, a joint project with Aristea Therapeutics

Published: May 02, 2023 by FierceBiotech

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count

CONTACT US

We offer built-to-order industry coverage for our clients. Click on any of the markets or drivers to see a sample intelligence map or call us for a free consultation.

Call Us

310.553.0008

Email Us

info@industryintel.com

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Latest Public Posts

Client-Centric Solutions at Industry Intelligence

September 7, 2023

Information Delivery with a Vision

August 8, 2023

Saving Our Planet with Lignocellulose

April 11, 2022

Useful Links

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

contact@industryintel.com
www.industryintel.com

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.